Rentschler doubles capacity with new manufacturing plant

By Gareth Macdonald contact

- Last updated on GMT

Related tags: Biotechnology

Rentschler doubles capacity with new manufacturing plant
Rentschler Biotechnologie has opened a facility at its site in Laupheim, Germany and plans to create 200 new jobs.

The plant – which cost €24m ($26m) - houses two 3,000 litre stainless steel bioreactors linked to a protein purification system. Clinical-stage protein therapeutics and commercial products will be made at the site.

Rentschler CEO Frank Mathias said: “An increase in sales of over 30% in the past two years has enabled us to make this significant investment. We have already received manufacturing orders for the new facility, extending into 2018​.”

He added that: “Increasingly, our growth is being driven by international business, with more and more orders coming from abroad, particularly the United States​."

Rentschler also said it plans to hire 200 employees, explaining this will include process engineers and laboratory technicians in bioprocess development and manufacturing as well as GMP (Good Manufacturing Practices) experts, as it continues to expand its business.

Expansion

The new facility is the second expansion Rentschler has undertaken in a year. In April​ last year the German contract manufacturing organisation (CMO) installed a single-use bioreactor at its older facility at the Laupheim site.

That expansion coincided with Rentschler being contracted to make Apeiron’s neuroblastoma candidate monoclonal antibody (mAb) APN311​.

A few months later the CMO was hired by Probiodrug​ to makes its Alzheimer’s disease drug candidate PBD-C06, a pGlu-Abeta-specific mAb.

Related news

Show more

Related products

show more

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 22-Jul-2019 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Related suppliers

Follow us

Products

View more

Webinars